Coloplast A/S Revised guidance for FY 2024/25

Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures Coloplast revises the guidance on organic growth and EBIT margin before special items for FY 2024/25. The organic growth is now expected to be around 7%, from previously 8-9%. The EBIT margin before special items is now expected to be 27-28%, from previously around 28%.  Key financial figures and developments in Q2:Group organic growth was 6% in Q2. The EBIT margin before special...

Humlebaek, 01/05/2025 (informazione.news - comunicati stampa - salute e benessere)

  

Coloplast will release its H1 2024/25 Interim Report on 6 May 2025 and will host a conference call on the same day at 11h CEST.

Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Aleksandra Dimovska
Vice President, Investor Relations
+45 4911 2458
dkadim@coloplast.com

Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2981
dksdk@coloplast.com

Jakob Danving Nielsen
Sr. Communications Manager
+45 4911 2229
dkjada@coloplast.com  

 

Attachment